Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (4)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CREATIVE REALITIES, INC.
Report date December 08, 2023 · Filed October 23, 2024
Section 16 reporting ended · disclosed 2024-10-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,037,404 |
Ending reported balance
After 2024-01-23 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2023-12-08 · Purchase · Acquired 1,000 · Balance 1,042,204 Row 2 · 2023-12-12 · Purchase · Acquired 10,000 · Balance 1,052,204 Row 3 · 2024-01-18 · Sale · Disposed 4,600 · Balance 1,047,604 Row 4 · 2024-01-22 · Sale · Disposed 4,800 · Balance 1,042,804 Row 5 · 2024-01-23 · Sale · Disposed 5,400 · Balance 1,037,404 |
DNA X, Inc.
Report date July 02, 2025 · Filed July 07, 2025
Section 16 reporting ended · disclosed 2025-07-07. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
HTG MOLECULAR DIAGNOSTICS, INC
Report date February 25, 2020 · Filed February 27, 2020
Section 16 reporting ended · disclosed 2020-02-27. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,297,173 |
Reported balance
After 2020-02-25 transaction · row 1
1 source rowRow 1 · 2020-02-25 · Other · Disposed 4,110,000 · Balance 2,297,173 F1: Surrendered to the Issuer in exchange for shares of the Issuer's newly designated Series A Convertible Preferred Stock, par value $0.001 per share ("Series A Preferred"). |
| Series A Convertible Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 1,167 |
Reported balance
After 2020-02-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-02-25 · Other · Acquired 1,167 · Balance 1,167 F2: Each share of Series A Preferred is convertible into 100 shares of the Issuer's common stock at the holder's election, subject to beneficial ownership limitations, and has no expiration date. F3: Issued in exchange for the surrender of shares of the Issuer's Common Stock. F4: As discussed above, the exercise of the Series A Preferred is subject to beneficial ownership limitations. The number of shares shown is the number not subject to such limitations. |
| Series A Convertible Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | IndirectLytton Kambara Foundation | 193 |
Reported balance
After 2020-02-25 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-02-25 · Purchase · Acquired 193 · Balance 193 F2: Each share of Series A Preferred is convertible into 100 shares of the Issuer's common stock at the holder's election, subject to beneficial ownership limitations, and has no expiration date. F4: As discussed above, the exercise of the Series A Preferred is subject to beneficial ownership limitations. The number of shares shown is the number not subject to such limitations. F5: Lytton Kambara Foundation is a non-profit entity for which Mr. Lytton has investment discretion. Mr. Lytton has no pecuniary interest in and disclaims beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
| Series A Convertible Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | IndirectAWL Family LLC | 96 |
Reported balance
After 2020-02-25 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-02-25 · Purchase · Acquired 96 · Balance 96 F2: Each share of Series A Preferred is convertible into 100 shares of the Issuer's common stock at the holder's election, subject to beneficial ownership limitations, and has no expiration date. F4: As discussed above, the exercise of the Series A Preferred is subject to beneficial ownership limitations. The number of shares shown is the number not subject to such limitations. F6: Mr. Lytton has no pecuniary interest in and disclaims any beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: Surrendered to the Issuer in exchange for shares of the Issuer's newly designated Series A Convertible Preferred Stock, par value $0.001 per share ("Series A Preferred").
F2: Each share of Series A Preferred is convertible into 100 shares of the Issuer's common stock at the holder's election, subject to beneficial ownership limitations, and has no expiration date.
F3: Issued in exchange for the surrender of shares of the Issuer's Common Stock.
F4: As discussed above, the exercise of the Series A Preferred is subject to beneficial ownership limitations. The number of shares shown is the number not subject to such limitations.
F5: Lytton Kambara Foundation is a non-profit entity for which Mr. Lytton has investment discretion. Mr. Lytton has no pecuniary interest in and disclaims beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F6: Mr. Lytton has no pecuniary interest in and disclaims any beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
LIQTECH INTERNATIONAL INC
Report date May 13, 2022 · Filed May 14, 2022
Section 16 reporting ended · disclosed 2022-05-14. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,926,957 |
Reported balance
After 2022-05-13 transaction · row 1
1 source rowRow 1 · 2022-05-13 · Purchase · Acquired 1,375,000 · Balance 2,926,957 |
| Pre-Funded Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 9,025,000 |
Reported balance
After 2022-05-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-05-13 · Purchase · Acquired 8,625,000 · Balance 9,025,000 F2: The pre-funded warrants do not have an expiration date. F3: The pre-funded warrants may be exercised to purchase shares of common stock of the issuer, subject to a 9.99% beneficial ownership limitation. |
| Common StockSEC Table I · non-derivative | IndirectSee Note | 717,891 |
Reported balance
Holding disclosure · report date 2022-05-13 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 717,891 F1: Mr. Lytton may be deemed to beneficially own these securities indirectly because he has investment discretion over the securities accounts of certain of his family members and their trusts, investment entities and foundations in which these securities are held. Mr. Lytton disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |
| Pre-Funded Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | IndirectSee Note 1 | 615,000 |
Reported balance
Holding disclosure · report date 2022-05-13 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 615,000 F2: The pre-funded warrants do not have an expiration date. F3: The pre-funded warrants may be exercised to purchase shares of common stock of the issuer, subject to a 9.99% beneficial ownership limitation. |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. Lytton may be deemed to beneficially own these securities indirectly because he has investment discretion over the securities accounts of certain of his family members and their trusts, investment entities and foundations in which these securities are held. Mr. Lytton disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
F2: The pre-funded warrants do not have an expiration date.
F3: The pre-funded warrants may be exercised to purchase shares of common stock of the issuer, subject to a 9.99% beneficial ownership limitation.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2025 Filed Jun 30, 2025 22:26 UTC | DNA X, Inc. SONM · Entity 8261 | SaleCommon Stock | 400,514 | $1.39 | $556,714.46 |
DisclosureSEC source: 0000935836-25-000440 · ownership.xml · nonDerivative · entry 2 LYTTON LAURENCE W · CIK 0001105806 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.30 to $1.47, inclusive. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 22:26 UTC | DNA X, Inc. SONM · Entity 8261 | SaleCommon Stock | 466,402 | $1.50 | $699,603.00 |
DisclosureSEC source: 0000935836-25-000440 · ownership.xml · nonDerivative · entry 1 LYTTON LAURENCE W · CIK 0001105806 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,514 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.28 to $1.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnote 2. Read SEC document |
| January 23, 2024 Filed Oct 23, 2024 23:34 UTC | CREATIVE REALITIES, INC. CREX · Entity 7331 | SaleCommon Stock | 5,400 | $2.96 | $15,985.08 |
DisclosureSEC source: 0000935836-24-000638 · ownership.xml · nonDerivative · entry 5 LYTTON LAURENCE W · CIK 0001105806 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,037,404 Read SEC document |
| January 22, 2024 Filed Oct 23, 2024 23:34 UTC | CREATIVE REALITIES, INC. CREX · Entity 7331 | SaleCommon Stock | 4,800 | $2.81 | $13,502.40 |
DisclosureSEC source: 0000935836-24-000638 · ownership.xml · nonDerivative · entry 4 LYTTON LAURENCE W · CIK 0001105806 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,042,804 Read SEC document |
| January 18, 2024 Filed Oct 23, 2024 23:34 UTC | CREATIVE REALITIES, INC. CREX · Entity 7331 | SaleCommon Stock | 4,600 | $2.67 | $12,283.84 |
DisclosureSEC source: 0000935836-24-000638 · ownership.xml · nonDerivative · entry 3 LYTTON LAURENCE W · CIK 0001105806 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,047,604 Read SEC document |
| December 12, 2023 Filed Oct 23, 2024 23:34 UTC | CREATIVE REALITIES, INC. CREX · Entity 7331 | PurchaseCommon Stock | 10,000 | $1.90 | $18,967.00 |
DisclosureSEC source: 0000935836-24-000638 · ownership.xml · nonDerivative · entry 2 LYTTON LAURENCE W · CIK 0001105806 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,052,204 Read SEC document |
| December 08, 2023 Filed Oct 23, 2024 23:34 UTC | CREATIVE REALITIES, INC. CREX · Entity 7331 | PurchaseCommon Stock | 1,000 | $1.96 | $1,955.00 |
DisclosureSEC source: 0000935836-24-000638 · ownership.xml · nonDerivative · entry 1 LYTTON LAURENCE W · CIK 0001105806 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,042,204 Read SEC document |
| May 13, 2022 Filed May 14, 2022 00:15 UTC | LIQTECH INTERNATIONAL INC LIQT · Entity 7695 | PurchasePre-Funded Common Stock Purchase Warrant · Derivative | 8,625,000 | $0.50 Strike: $0.00 | $4,303,875.00 |
DisclosureSEC source: 0001567619-22-010601 · doc1.xml · derivative · entry 3 LYTTON LAURENCE W · CIK 0001105806 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,025,000 Underlying: Common Stock · 8,625,000 shares Expires not disclosed F2 · derivative.expiration_date: The pre-funded warrants do not have an expiration date. F3 · derivative.underlying_shares: The pre-funded warrants may be exercised to purchase shares of common stock of the issuer, subject to a 9.99% beneficial ownership limitation. Read SEC document |
| May 13, 2022 Filed May 14, 2022 00:15 UTC | LIQTECH INTERNATIONAL INC LIQT · Entity 7695 | PurchaseCommon Stock | 1,375,000 | $0.50 | $687,500.00 |
DisclosureSEC source: 0001567619-22-010601 · doc1.xml · nonDerivative · entry 1 LYTTON LAURENCE W · CIK 0001105806 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,926,957 Read SEC document |
| January 25, 2022 Filed Jan 25, 2022 22:44 UTC | LIQTECH INTERNATIONAL INC LIQT · Entity 7695 | PurchaseCommon Stock | 100 | $5.44 | $544.00 |
DisclosureSEC source: 0001567619-22-001726 · doc1.xml · nonDerivative · entry 3 LYTTON LAURENCE W · CIK 0001105806 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,551,957 Read SEC document |
| January 24, 2022 Filed Jan 25, 2022 22:44 UTC | LIQTECH INTERNATIONAL INC LIQT · Entity 7695 | PurchaseCommon Stock | 16,089 | $5.24 | $84,251.66 |
DisclosureSEC source: 0001567619-22-001726 · doc1.xml · nonDerivative · entry 2 LYTTON LAURENCE W · CIK 0001105806 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,551,857 F1 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.1426 to $5.3903 per share. The filers undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within this range. Read SEC document |
| January 21, 2022 Filed Jan 25, 2022 22:44 UTC | LIQTECH INTERNATIONAL INC LIQT · Entity 7695 | PurchaseCommon Stock | 20,000 | $5.40 | $108,000.00 |
DisclosureSEC source: 0001567619-22-001726 · doc1.xml · nonDerivative · entry 1 LYTTON LAURENCE W · CIK 0001105806 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,535,768 Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 00:42 UTC | LIQTECH INTERNATIONAL INC LIQT · Entity 7695 | PurchaseCommon Stock | 10,900 | $5.95 | $64,855.00 |
DisclosureSEC source: 0001567619-22-000670 · doc1.xml · nonDerivative · entry 2 LYTTON LAURENCE W · CIK 0001105806 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,515,768 F2 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.94 to $5.95 per share. The filers undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within this range. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 00:42 UTC | LIQTECH INTERNATIONAL INC LIQT · Entity 7695 | PurchaseCommon Stock | 12,785 | $5.95 | $76,070.75 |
DisclosureSEC source: 0001567619-22-000670 · doc1.xml · nonDerivative · entry 1 LYTTON LAURENCE W · CIK 0001105806 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,504,868 F1 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.90 to $6.00 per share. The filers undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within this range. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 00:00 UTC | LIQTECH INTERNATIONAL INC LIQT · Entity 7695 | PurchaseCommon Stock | 15,100 | $5.16 | $77,909.96 |
DisclosureSEC source: 0001567619-21-022458 · doc1.xml · nonDerivative · entry 3 LYTTON LAURENCE W · CIK 0001105806 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,492,083 F3 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.96 to $5.29 per share. The filers undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within this range. Read SEC document |
| December 21, 2021 Filed Dec 23, 2021 00:00 UTC | LIQTECH INTERNATIONAL INC LIQT · Entity 7695 | PurchaseCommon Stock | 44,895 | $5.04 | $226,320.18 |
DisclosureSEC source: 0001567619-21-022458 · doc1.xml · nonDerivative · entry 2 LYTTON LAURENCE W · CIK 0001105806 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,476,983 F2 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.96 to $5.10 per share. The filers undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within this range. Read SEC document |
| December 20, 2021 Filed Dec 23, 2021 00:00 UTC | LIQTECH INTERNATIONAL INC LIQT · Entity 7695 | PurchaseCommon Stock | 21,100 | $4.88 | $102,991.21 |
DisclosureSEC source: 0001567619-21-022458 · doc1.xml · nonDerivative · entry 1 LYTTON LAURENCE W · CIK 0001105806 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,432,088 F1 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.78 to $4.95 per share. The filers undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within this range. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:40 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | PurchaseSeries A Convertible Preferred Stock · Derivative | 96 | $59.00 Strike: $0.00 | $5,664.00 |
DisclosureSEC source: 0001567619-20-004990 · doc1.xml · derivative · entry 4 LYTTON LAURENCE W · CIK 0001105806 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · AWL Family LLC Disclosed balance after: 96 Underlying: Common Stock · 9,600 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Series A Preferred is convertible into 100 shares of the Issuer's common stock at the holder's election, subject to beneficial ownership limitations, and has no expiration date. F4 · shares: As discussed above, the exercise of the Series A Preferred is subject to beneficial ownership limitations. The number of shares shown is the number not subject to such limitations. F2 · derivative.exercise_date: Each share of Series A Preferred is convertible into 100 shares of the Issuer's common stock at the holder's election, subject to beneficial ownership limitations, and has no expiration date. F2 · derivative.expiration_date: Each share of Series A Preferred is convertible into 100 shares of the Issuer's common stock at the holder's election, subject to beneficial ownership limitations, and has no expiration date. F6 · ownership.nature: Mr. Lytton has no pecuniary interest in and disclaims any beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:40 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | PurchaseSeries A Convertible Preferred Stock · Derivative | 193 | $59.00 Strike: $0.00 | $11,387.00 |
DisclosureSEC source: 0001567619-20-004990 · doc1.xml · derivative · entry 3 LYTTON LAURENCE W · CIK 0001105806 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Lytton Kambara Foundation Disclosed balance after: 193 Underlying: Common Stock · 19,300 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Series A Preferred is convertible into 100 shares of the Issuer's common stock at the holder's election, subject to beneficial ownership limitations, and has no expiration date. F4 · shares: As discussed above, the exercise of the Series A Preferred is subject to beneficial ownership limitations. The number of shares shown is the number not subject to such limitations. F2 · derivative.exercise_date: Each share of Series A Preferred is convertible into 100 shares of the Issuer's common stock at the holder's election, subject to beneficial ownership limitations, and has no expiration date. F2 · derivative.expiration_date: Each share of Series A Preferred is convertible into 100 shares of the Issuer's common stock at the holder's election, subject to beneficial ownership limitations, and has no expiration date. F5 · ownership.nature: Lytton Kambara Foundation is a non-profit entity for which Mr. Lytton has investment discretion. Mr. Lytton has no pecuniary interest in and disclaims beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:40 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | OtherSeries A Convertible Preferred Stock · Derivative | 1,167 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-004990 · doc1.xml · derivative · entry 2 LYTTON LAURENCE W · CIK 0001105806 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,167 Underlying: Common Stock · 116,700 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Series A Preferred is convertible into 100 shares of the Issuer's common stock at the holder's election, subject to beneficial ownership limitations, and has no expiration date. F3 · kind: Issued in exchange for the surrender of shares of the Issuer's Common Stock. F4 · shares: As discussed above, the exercise of the Series A Preferred is subject to beneficial ownership limitations. The number of shares shown is the number not subject to such limitations. F3 · price: Issued in exchange for the surrender of shares of the Issuer's Common Stock. F2 · derivative.exercise_date: Each share of Series A Preferred is convertible into 100 shares of the Issuer's common stock at the holder's election, subject to beneficial ownership limitations, and has no expiration date. F2 · derivative.expiration_date: Each share of Series A Preferred is convertible into 100 shares of the Issuer's common stock at the holder's election, subject to beneficial ownership limitations, and has no expiration date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:40 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | OtherCommon Stock | 4,110,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-004990 · doc1.xml · nonDerivative · entry 1 LYTTON LAURENCE W · CIK 0001105806 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,297,173 F1 · kind: Surrendered to the Issuer in exchange for shares of the Issuer's newly designated Series A Convertible Preferred Stock, par value $0.001 per share ("Series A Preferred"). F1 · price: Surrendered to the Issuer in exchange for shares of the Issuer's newly designated Series A Convertible Preferred Stock, par value $0.001 per share ("Series A Preferred"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.